Stockwinners Market Radar for July 18, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:39 EDT LeMaitre CEO sells $4.97M in common stock - In a regulatory filing, LeMaitre disclosed that its CEO George Lemaitre sold 57.4K shares of common stock on July 16th in a total transaction size of $4.97M.

20:02 EDT Cathie Wood's ARK Investment buys 60K shares of Beam Therapeutics today

19:11 EDT Dave issues statement regarding CFPB proposal - Dave Inc. issued a statement regarding a proposal from the Consumer Financial Protection Bureau: "We are closely monitoring the recently proposed interpretive ruling from the CFPB around paycheck advance and earned wage access ("EWA"), a model which Dave was originally founded on, but transitioned away from beginning in 2022 due to a lack of certainty around the regulations," said Jason Wilk, Founder and CEO of Dave. "Dave's ExtraCash product is structured as a bank-originated overdraft with optional fees, which combats the excessive fees found at incumbent banks. As a result, we believe ExtraCash and our optional fees sit within the overdraft regulatory framework that is distinguished from EWA and paycheck advance products."

18:00 EDT Four Corners Property Trust acquires Buffalo Wild Wings property for $2.5M - Four Corners Property Trust announces the acquisition of a Buffalo Wild Wings property for $2.5 million. The property is located in a highly trafficked corridor in Texas and corporate-operated under a net lease. The transaction was priced at a cap rate in range with previous FCPT transactions.

17:39 EDT Diamond Offshore in drillship commitment for Ocean BlackRhino in Gulf of Mexico - Diamond Offshore Drilling announced that it has entered into a contract with BOE Exploration & Production for the Ocean BlackRhino for work in the U.S. Gulf of Mexico. The Ocean BlackRhino was awarded a contract with a minimum duration of 180 days for a total value of approximately $89M, excluding mobilization and any additional services. The contract also includes two additional option periods. Work under the new contract is expected to commence late in the first quarter or early second quarter of 2025. Bernie Wolford, Jr., President and Chief Executive Officer, commented, "This contract reflects the BlackRhino's exceptional track record and is the third in a series of follow-on contracts for the rig after its current contract."

17:28 EDT OpenAI debuts GPT-4o mini, advancing cost-efficient intelligence - "OpenAI is committed to making intelligence as broadly accessible as possible. ... we're announcing GPT-4o mini, our most cost-efficient small model. We expect GPT-4o mini will significantly expand the range of applications built with AI by making intelligence much more affordable. GPT-4o mini scores 82% on MMLU and currently outperforms GPT-41 on chat preferences in LMSYS leaderboard(opens in a new window). It is priced at 15 cents per million input tokens and 60 cents per million output tokens, an order of magnitude more affordable than previous frontier models and more than 60% cheaper than GPT-3.5 Turbo. GPT-4o mini enables a broad range of tasks with its low cost and latency, such as applications that chain or parallelize multiple model calls (e.g., calling multiple APIs), pass a large volume of context to the model (e.g., full code base or conversation history), or interact with customers through fast, real-time text responses (e.g., customer support chatbots). ..GPT-4o mini supports text and vision in the API, with support for text, image, video and audio inputs and outputs coming in the future. The model has a context window of 128K tokens, supports up to 16K output tokens per request, and has knowledge up to October 2023. Thanks to the improved tokenizer shared with GPT-4o, handling non-English text is now even more cost effective, said the company in its latest post...The Fly notes that Microsoft owns roughly 49% of OpenAI's equity, having invested $13B... It also provides computing resources to OpenAI through its Microsoft Azure cloud platform. Reference Link

17:13 EDT Netflix says engagement on ad plans similar to ad-free plans - Says generative AI has "tremendous potential" to improve discovery and recommendation systems. Says key to success is "quality at all levels." Says impact of generative AI on content creation is "hard to predict" at this point. Says AI could be a good way to "help storytellers tell great stories."

17:10 EDT Textron awarded $312.39M Navy contract modification - Textron was awarded a $312.39M cost reimbursable, not-to-exceed modification to a previously awarded contract for the procurement of material and recurring and non-recurring activities for up to nine future ship to shore connector landing craft air cushion craft. Work is expected to be completed by October 2025. FY24 shipbuilding and conversion funds in the amount of $163.54M; FY22 shipbuilding and conversion funds in the amount of $43.99M and fiscal FY23 shipbuilding and conversion funds in the amount of $30.55M, will be obligated at time of award and will not expire at the end of the current fiscal year. Naval Sea Systems Command is the contracting activity.

16:59 EDT Intuitive Surgical narrows FY24 procedure growth view to 15.5%-17% from 14%-17% - Raises FY24 gross profit margin view to 68.5%-69% of net revenue from 67%-68%. Lowers FY24 operating expense view to 10%-13% from 11%-15%. Backs FY24 capital expenditures view $1B-$1.2B. Backs FY24 effective tax rate view 22%-24%. Sees DaVinci 5 placements up modestly quarter-to-quarter. Says would not expect trade in cycle to emerge quickly. Says cleared for thoracic procedures. Says supporting Davinci 5 launch. Says expects Davinci 5 placements to be constrained in the first half of 2025. Says expects increased depreciation expense in the second half. Says Q2 growth was led by procedures in general surgery. Comments and guidance taken from Q2 earnings conference call.

16:35 EDT Western Alliance reports Q2 net interest margin 3.63% vs. 3.42% last year - Western Alliance stated: "The Company recorded a provision for credit losses of $37.1M in the second quarter 2024, an increase of $21.9 million from $15.2 million in the first quarter 2024, and an increase of $15.3 million from $21.8 million in the second quarter 2023. The provision for credit losses during the second quarter 2024 is primarily reflective of loan growth and net-charge offs of $22.8 million. The Company's net interest margin in the second quarter 2024 was 3.63%, an increase from 3.60% in the first quarter 2024, and an increase from 3.42% in the second quarter 2023. The increase in net interest margin from the first quarter 2024 was driven by growth in average earning asset balances outpacing interest-bearing deposits. The increase in net interest margin from the second quarter 2023 was driven by higher average HFI loan and securities balances and a decrease in average short-term borrowings, partially offset by higher average deposit balances."

16:32 EDT Air Lease delivers first of 19 new A321-200neo aircraft to Condor - Air Lease "announced the delivery of one new Airbus A321-200neo to Condor. This aircraft is the first of 19 new Airbus aircraft confirmed to deliver to the airline from ALC's orderbook with Airbus through 2027, including 17 A321-200neos and two A320-200neos. In addition to these aircraft, ALC currently has three A321s and two A320s on long-term lease to the airline."

16:23 EDT Oneok expands refined products pipeline to greater Denver area - Oneok plans to expand its pipeline capacity connecting Mid-Continent and Gulf Coast refined products supply with the greater Denver area to meet growing demand and increase connectivity with Denver International Airport. The project includes construction of a new 230-mile, 16-inch diameter pipeline from Scott City, Kansas, to DIA and the addition or upgrading of certain pump stations along the existing refined products pipeline system. Total system capacity will increase by 35,000 barrels per day (and will have additional expansion capabilities. The project is expected to cost approximately $480M and be completed in mid-2026. Following the close of an open season earlier this year, the project is fully subscribed under long-term contracts.

16:20 EDT TechnipFMC announces 'large' iEPCI contract for Katlan development - Technip has been awarded a large integrated Engineering, Procurement, Construction, and Installation, iEPCI, contract by Energean for its Katlan development in the Mediterranean Sea. This is Energean's first project to use TechnipFMC's configure-to-order Subsea 2.0(R) production systems. The award follows an integrated Front End Engineering and Design study by TechnipFMC, which optimized the commercial and technological solution for the field. The contract covers the design, manufacture, and installation of the production systems, pipe, umbilicals, and subsea structures. For TechnipFMC, a "large" contract is between $500M and $1B. This award was included in second quarter Subsea inbound orders.

16:18 EDT Dover acquires Demaco Holland B.V., no terms disclosed - Dover announced that it has acquired Demaco Holland B.V.. Demaco is now part of OPW's Clean Energy Solutions business within Dover's Clean Energy & Fueling segment.

16:15 EDT Everest Group announces new leadership appointments - Everest Group announced two key leadership appointments to the Company's world-class claims operations. Andrew McBride has been promoted to Group Chief Claims Officer, where he will lead claims across Everest's Insurance and Reinsurance divisions, working closely with the Company's global leaders to drive claims excellence and superior service. Mr. McBride was most recently Global Head of Claims at Everest Insurance(R), where he developed a highly talented team, with enhanced capabilities, service and expertise. Prior to joining Everest in 2021, Mr. McBride served as Executive Vice President, Claims at Chubb and led claims functions at ACE, QBE Insurance Group in Europe, and Aon. Everest also announced Lope Garcia has joined the Company's Reinsurance division as Global Reinsurance Chief Claims Officer. Based in Miami, FL, he reports to Mr. McBride and will work closely with Jill Beggs, Reinsurance Chief Operating Officer, and her Global Executive team to direct the function's strategy and operations.

16:11 EDT Blackbaud raises stock repurchase authorization to $800M - Blackbaud announced its board of directors has reauthorized, expanded and replenished the company's existing stock repurchase program, raising the total capacity from $500M to $800M available for repurchases of the company's common stock.

16:09 EDT Metropolitan Bank reports Q2 allowance for credit losses at $60.0M - The company states: "Credit quality remains stable. The ratio of non-performing loans to total loans declined to 0.53% at June 30, 2024 compared to 0.91% at March 31, 2024 due to one multi-family loan relationship that was returned to accrual status. The ratio of non-performing loans to total loans was 0.47% at June 30, 2023. The allowance for credit losses was $60.0 million at June 30, 2024, an increase of $1.5 million from March 31, 2024, which includes a provision related to a single C&I loan. "

16:08 EDT Noble Corp. plans to delist from NASDAQ Copenhagen - Noble Corporation announced its intention to voluntarily delist from NASDAQ Copenhagen. Noble will remain traded on the NYSE, as Noble's primary listing exchange. The company believes that the trading volume of its share entitlements on NASDAQ no longer justifies the expense and administrative requirements associated with maintaining this dual listing. NYSE accounts for approximately 99% of its trading volume. Noble anticipates such delisting will be effective in late 2024 or early 2025. Shareholders may transfer their Danish Shares currently trading on NASDAQ to Noble shares trading on NYSE or sell their Danish Shares on NASDAQ prior to the effective date of the delisting. The company has not filed, and has not yet determined when it will file, a formal delisting request with NASDAQ.

16:07 EDT ICF International awarded $88M contract - ICF was recently awarded a new subcontract to continue modernizing and executing the Centers for Medicare and Medicaid Services Quality Payment Program. The contract has a value of $88 million and a term of nearly five years, including a six-month base, four one-year option periods and one four-month option period.

16:06 EDT Intellicheck announces CFO transition - Intellicheck announced COO/CFO Jeffrey Ishmael will be departing the Company. "Jeff joined Intellicheck to put into place the changes needed to further our financial organization and build the financial and analytical platforms to support continued growth and success. With the successful changes in place, Jeff determined that it was the appropriate time to transition leadership," said Intellicheck CEO Bryan Lewis. "We are grateful to him for the many contributions he has made and we wish him well in his future endeavors. Looking forward, we have commenced a search to identify our next CFO and we anticipate that we will make an announcement in the near future. In the meantime, Jeff will continue as CFO through the filing of the second quarter financials so that he and our dedicated financial team can complete a seamless transition."

16:05 EDT Netflix says 'continue to invest in and expand entertainment offering' - Netflix said in its quarterly letter: "We continue to invest in and expand our entertainment offering - as well as build our reach, recommendations and fandom - so that we can extend our lead with consumers, and sustain healthy revenue and profit growth as a business."

16:04 EDT Netflix says 'making steady progress scaling ads business' - Netflix said in its quarterly letter: "We're making steady progress scaling our ads business. Ads tier membership grew 34% quarter on quarter, and we're building an in-house ad tech platform that we'll test in Canada in 2024 and launch more broadly in 2025."

16:01 EDT Netflix reports Q2 global streaming paid net additions of 8.05M - Netflix said in its quarterly letter to investors: "Global revenue was 1% higher than our beginning of quarter guidance due primarily to stronger-than-forecasted paid net additions of 8.0M vs. 5.9M in Q2'23."

15:28 EDT New Apple Immersive Video series, films, concerts to debut starting July 18 - "Starting this week, Apple is releasing all-new series and films captured in Apple Immersive Video that will debut exclusively on Apple Vision Pro. Apple Immersive Video is a remarkable storytelling format that leverages 3D video recorded in 8K with a 180-degree field of view and Spatial Audio to transport viewers to the center of the action. Boundless, a new series that invites viewers to experience once-in-a-lifetime trips from wherever they are, premieres at 6 p.m. PT today, July 18, with "Hot Air Balloons." The next installment of Wild Life, the nature documentary series that brings viewers up close to some of the most charismatic creatures on the planet, premieres in August. Elevated, an aerial travel series that whisks viewers around iconic vistas from staggering heights, will launch in September," said Apple inpart, in an ealier blog post. Reference Link

15:01 EDT Benson Hill announces 1-for-35 reverse stock split - Benson Hill announced that, following stockholder approval at the company's annual meeting held this morning, its board of directors has approved a reverse stock split of the company's common stock, par value $0.0001 per share, at a ratio of one-for-thirty five. The company anticipates that the Reverse Stock Split will take effect at 4:01 p.m. Eastern Time/3:01 p.m. Central Time on July 18 and will be reflected in the market at the start of trading on the New York Stock Exchange tomorrow, Friday, July 19, 2024, on a split-adjusted basis. The company's shares will continue to trade on the NYSE under the symbol "BHIL" under a new CUSIP number (082490202). The company's publicly traded warrants will continue to be traded over-the-counter under the symbol BHILW under the same CUSIP number (082490111).

14:16 EDT Allegiant Travel drops 10% to $46.51 after suspending dividend

14:13 EDT Ubisoft says 'Rainbow Six Mobile,' 'Division Resurgence' not expected in FY25 - The line-up for the rest of FY25 includes "Assassin's Creed Shadows" and "Star Wars Outlaws." "Rainbow Six Mobile" and "The Division Resurgence" are no longer expected in FY25 as the teams are taking the necessary time to ensure that these experiences deliver on expectations with optimized KPIs in the context of a demanding yet very large market. The Company confirms its financial targets. It expects solid net bookings growth, a slight increase in non-IFRS operating income and growing non-IFRS Cash Flow from Operations leading to positive Free Cash Flow.

13:14 EDT Tesla California registrations dropped 24.1% in Q2, agency says - The California New Car Dealers Association yesterday released its California auto outlook covering the first half of 2024. California's new light vehicle registrations fell by 0.7% year-to-date compared to last year, totaling 892,363. Tesla's future "appears to be dwindling as the brand's sales continue to decline in the Golden State," according to the association. The company's registrations are down 17% year-to-date compared to last year. While the Model Y remains the top-selling car in California, "Tesla sales may have peaked," it writes. The agency says the new data marks the brand's third consecutive quarter with registration declines. Registrations dipped 24.1% in Q2, 7.8% in Q1, and 9.8 in Q4 of last year, it added. Reference Link

12:20 EDT BRF falls after Newcastle disease found in Brazil - Brazil's Ministry of Agriculture and Livestock confirmed that on Wednesday, July 17, an outbreak of Newcastle disease in a commercial poultry establishment, located in the municipality of Anta Gorda, in the state of Rio Grande do Sul. The positive diagnosis was recognized by the World Organization for Animal Health as an international reference laboratory for the diagnosis of Newcastle disease. Shares of Brazil meat producers are moving lower today, including BRF S.A. (BRFS), Marfrig (MRRTY) and JBS S.A. (JBSAY).

12:00 EDT Forestar Group falls -15.9% - Forestar Group is down -15.9%, or -$5.73 to $30.27.

12:00 EDT Infosys rises 8.9% - Infosys is up 8.9%, or $1.83 to $22.36.

12:00 EDT Barnes & Noble Education rises 23.5% - Barnes & Noble Education is up 23.5%, or $1.94 to $10.21.

11:25 EDT United says doesn't have date yet for Investor Day event

11:13 EDT Ardelyx files lawsuit against CMS over tenapanor and ESRD PPS - Ardelyx yesterday announced that, in partnership with the American Association of Kidney Patients, or AAKP, and the National Minority Quality Forum, or NMQF, it has filed a lawsuit against the U.S. Department of Health and Human Services and the Centers for Medicare and Medicaid Services, or CMS, claiming that CMS's plan to include XPHOZAH, or tenapanor, along with all other oral-only phosphate lowering therapies, or PLTs, in the End-Stage Renal Disease Prospective Payment System, or ESRD PPS, will significantly and negatively impact patient choice of and timely access to important medications. "The lawsuit claims that CMS has violated its statutory and regulatory authority under the Medicare Improvements for Patients and Providers Act, which established the ESRD PPS bundled payment system for dialysis services in 2008. Specifically, the lawsuit claims that CMS's plan to move XPHOZAH, along with all oral-only PLTs, into the ESRD PPS is inconsistent with MIPPA's statutory provision, and contradicts CMS's own regulations. XPHOZAH and other PLTs, which are currently available to patients under outpatient pharmacy benefit plans such as Medicare Part D, are not administered by dialysis providers and cannot be taken during the delivery of maintenance dialysis. The plaintiffs seek relief under the Administrative Procedure Act to enjoin CMS from proceeding with its plan to include XPHOZAH in the ESRD PPS and eliminate coverage under Medicare Part D beginning on January 1, 2025," the company stated.

11:02 EDT Amkor, Infineon sign MOU to stimulate sustainability across supply chain - Infineon Technologies (IFNNY) has signed a Memorandum of Understanding with Amkor Technology (AMKR) with a joint commitment to stimulate decarbonization and sustainability strategies across the supply chain. Expanding their partnership towards sustainability is the next step in the sustainability journey of both companies. Infineon and Amkor intend to fully leverage their classical Outsourced Semiconductor Assembly and Test business relationship in order to effectively tackle emissions along their supply chain. In April, both companies announced to operate a dedicated packaging and test center at Amkor's manufacturing site in Porto, Portugal. As part of the cooperation for climate protection, Infineon and Amkor will actively engage with common suppliers to help them develop and implement effective decarbonization strategies. This will involve workshops, meetings, and the sharing of best practices and learnings related to decarbonization. The aim is to identify areas for improvement and support suppliers in setting science-based emissions reduction targets in line with the Science Based Targets initiative. Both companies are committed to providing ongoing guidance, fostering exchange, and tracking progress to drive continuous improvement across the common supply chain.

10:49 EDT United Airlines 'encouraged' by yield improvement in second half of Q3

10:35 EDT United sees domestic industry capacity growth moderating by 5pts by Q4 vs. Q2

10:24 EDT FDA authorizes marketing of seven e-cigarette products in U.S. - The U.S. Food and Drug Administration announced it authorized the marketing of seven e-cigarette products in the United States through the premarket tobacco product application, or PMTA, pathway. Following an extensive scientific review, FDA issued marketing granted orders to R.J. Reynolds Vapor Company for the Vuse Alto Power Unit and six Vuse Alto tobacco-flavored pods, which are sealed, pre-filled, and non-refillable, the FDA stated. Publicly traded companies in the tobacco products space include Altria Group (MO), British American Tobacco (BTI), Imperial Brands (IMBBY) and Philip Morris (PM). Reference Link

10:04 EDT On Location named official hospitality provider of FIFA World Cup 26 - FIFA has appointed On Location as the Official Hospitality Provider of the FIFA World Cup 26, which will take place across Canada, Mexico and the USA from 11 June to 19 July 2026. Chosen following a thorough selection process, On Location will help FIFA deliver its biggest-ever and most dynamic hospitality programme for the FIFA World Cup 26, offering ticket-inclusive fan experience packages for the world's biggest single-sport event. From die-hard football fans to friends and families, and to companies hosting guests or employees, FIFA and On Location will provide options to suit all types of fans. As the Official Hospitality Provider of the FIFA World Cup 26, On Location will have exclusive global rights to promote, sell and operate the Official Hospitality Programme at the 16 state-of-the-art stadiums - including five at which it has previously delivered Super Bowl hospitality - across the tournament's Host Cities.

10:03 EDT Patterson Dental, Pearl partner to advance dental AI in Canada - Pearl and Patterson Dental Canada announced a collaboration to expand access to Pearl's Second Opinion AI disease detection capabilities within the Canadian dental market. Pearl's real-time pathology detection AI software, Second Opinion, assists dentists in their radiologic evaluation and case presentation of dental conditions commonly found in dental x-rays, including caries, bone loss, calculus, and more. The technology, which received its Medical Device Establishment License from Health Canada in 2021, enables dentists to read patient x-rays more accurately and efficiently, enhancing their clinical performance and patient communication.

10:01 EDT Forestar Group falls -10.8% - Forestar Group is down -10.8%, or -$3.88 to $32.12.

10:00 EDT SelectQuote rises 5.9% - SelectQuote is up 5.9%, or 22c to $3.95.

10:00 EDT D.R. Horton rises 8.3% - D.R. Horton is up 8.3%, or $13.07 to $170.59.

09:58 EDT Glass Lewis recommends Enhabit stockholders vote for three AREX nominees - AREX Capital Management, the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, announced that Glass, Lewis & Co. has recommended that Enhabit's stockholders support significant boardroom change by voting for three of its director candidates at the Company's 2024 Annual Meeting of Stockholder on July 25, 2024. Glass Lewis recommends that stockholders elect Maxine Hochhauser, Mark W. Ohlendorf, and Dr. Gregory S. Sheff to Enhabit's board of directors. Previously, Institutional Shareholder Services Inc. recommended that stockholders elect three of AREX's director candidates. In its report, Glass Lewis made the following observations regarding the need for boardroom change at Enhabit: "... [T]here is a valid case to be made for supporting at least incremental change to the Company's board, given the Company's financial underperformance relative to its closest peers, the Company's missteps in the strategic review process, and the relevant experience and expertise of the Dissident Nominees... [T]he TSR of the Company has significantly lagged behind its closest industry peers and has trailed the average and median returns of the Proxy Peer Groups for most of the selected timeframes... [T]he election of these three Dissident Nominees will facilitate the inclusion of fresh perspectives and relevant expertise..."

09:49 EDT D.R. Horton rises 5.7% - D.R. Horton is up 5.7%, or $8.92 to $166.43.

09:47 EDT Infosys rises 9.2% - Infosys is up 9.2%, or $1.89 to $22.42.

09:47 EDT Domino's Pizza falls -11.6% - Domino's Pizza is down -11.6%, or -$55.02 to $418.25.

09:44 EDT Stardust Power Inc trading resumes

09:43 EDT NaaS Technology trading resumes

09:38 EDT NaaS Technology trading halted, volatility trading pause

09:35 EDT Volcon regains compliance under Nasdaq listing rules - Volcon was notified by Nasdaq's Hearing Panel that it has regained compliance with Nasdaq's listing rules, subject to Nasdaq Discretionary Panel Monitor for a period of one year.

09:32 EDT Allegiant Travel names Gregory Anderson as CEO, succeeding Maurice Gallagher - Allegiant Travel announced that Gregory Anderson has been named CEO and President of the company, succeeding Maurice Gallagher, who will be retiring from that role effective September 1. Gallagher will continue to serve the company as Executive Chairman of the Board. Anderson will join the Board at that time. Anderson joined Allegiant in 2010 and steadily rose through the management ranks. He has held several leadership positions during his tenure, including previously serving as chief financial officer and was instrumental in steering the company through the pandemic, one of the most financially challenging times in the history of the airline industry. Prior to joining Allegiant, Anderson worked for U.S. Airways and Ernst and Young, where his primary focus was the commercial aviation sector.

09:18 EDT Bravo Multinational establishes Mobile 13 subsidiary - Bravo Multinational announces corporate update. Bravo is entering the telecommunications sector through its newly established, wholly owned subsidiary, Mobile 13, Inc., a Mobile Virtual Network Operator that will provide mobile phone services to consumers in 50 states and Puerto Rico. An MVNO provides cellular connectivity services by leasing network infrastructure from the major Mobile Network Operators. The Company, through this subsidiary, is planning to become a Mobile Virtual Network Enabler, which means it will offer a comprehensive platform for other MVNOs to launch their services quickly and efficiently. If the Company is successful, it could become a key player in the telecom industry, capable of generating revenue by supporting other MVNOs. As part of the Company's business plan, it intends to target other MVNOs to expand its market presence and capabilities.

09:17 EDT CommScope to sell OWN segment, DAS business unit to Amphenol for $2.1B - CommScope (COMM) announced it has entered into a definitive agreement to sell its Outdoor Wireless Networks, or OWN, segment as well as the Distributed Antenna Systems, or DAS, business unit of its Networking, Intelligent Cellular & Security Solutions segment to Amphenol Corporation (APH). OWN provides wireless infrastructure for mobile networks, including macro and small cell site solutions. The DAS business provides solutions for cellular infrastructure inside venues, campuses and enterprises. CommScope will receive approximately $2.1B in cash, to be paid by Amphenol upon closing. The sale is expected to close within the first half of 2025, subject to customary closing conditions, including receipt of applicable regulatory approvals. "CommScope has a strong reputation for driving innovation and value for our customers. This transaction allows CommScope to increase focus and further strengthen its CommScope NEXT priorities with its remaining segments and business units. We believe CommScope's OWN and DAS businesses are positioned to continue to perform well under Amphenol's leadership," said Chuck Treadway, CEO, CommScope.

09:14 EDT Hasbro names Microsoft's John Hight as President of Wizards - Hasbro (HAS) announced the appointment of two leaders to its Executive Leadership Team. John Hight will join as President of Wizards of the Coast and Digital Gaming, and Holly Barbacovi will take on the role of Chief People Officer. John Hight, a gaming industry titan, joins Hasbro as President of Wizards of the Coast and Digital Gaming. John previously served as Senior Vice President and General Manager of the Warcraft Franchise at Blizzard Entertainment (MSFT), overseeing all development and commercial activities for World of Warcraft, Hearthstone, and Warcraft Rumble. During his 12-year tenure at Blizzard, John directed development efforts for multiple World of Warcraft expansions, Diablo III: Reaper of Souls, and Diablo III on console. John's addition marks a significant step in Hasbro's strategic focus on digital experiences and video games. As President, John's role will include oversight of Hasbro's network of gaming studios and digital licensing agreements. He will also lead strategy for MAGIC: THE GATHERING and DUNGEONS & DRAGONS while driving continued global growth for the division and uncovering new storytelling tabletop and digital experiences.

09:13 EDT Abbott seeing 'broad-based growth' across the portfolio - Seeing positive contribution from gross margin expansion. Says well positioned to capitalize on secular demand trends. Comments taken from Q2 earnings conference call.

09:12 EDT LiqTech delivers produced water treatment pilot unit in Middle East - LiqTech has successfully delivered a commercial pilot unit for the filtration of oil and gas produced water to National Energy Services Reunited, or NESR, a provider of integrated energy services in the Middle East and North Africa. The containerized system was delivered to NESR in June and will be used at customers' sites in the Gulf Cooperation Council Countries to demonstrate and document the efficiency of LiqTech's silicon carbide ceramic ultrafiltration technology in treating produced water to facilitate re-injection and beneficial reuse and meet current and future regulatory requirements. LiqTech currently has one full-scale commercial test unit for produced water in operation in the Middle East region that was deployed in May 2022 by a major oil and gas operator in the Middle East.

09:11 EDT NextTrip partner with Dooya Media Group to launch Compass.TV - NextTript has partnered with Dooya Media Group to deliver Compass.TV, an owned and operated travel discovery channel and app that seamlessly translates content into commerce opportunities using the NextTrip Booking Engine. The channel aims to be the premier go-to source for travel information, inspiration, and entertainment. Compass.TV enables viewers to virtually explore places they have always wanted to visit through the eyes of experienced globetrotters and stories shared by local insiders. The channel will also spotlight various accommodation types, local foods, and must-visit spots to help viewers create a memorable travel itinerary, part of an end-to-end content ecosystem designed to capture advertising, build brand awareness, reward loyalty and drive bookings linked to NextTrip's Travel Magazine and forthcoming MyBucketList platform. Slated to go live in September 2024, Compass.TV will be available to watch on numerous digital platforms, including iOS and Android applications and web browsers. In the months following the launch, NextTrip plans to extend Compass.TV's availability to key partners such as Roku, Apple TV and Amazon Fire TV.

09:10 EDT Hollysys announces expected completion date of merger with Ascendent - Hollysys expects to complete its merger transaction with a buyer controlled by Ascendent Capital Partners as soon as July 25. The parties have successfully obtained all necessary approvals and expect to satisfy all closing conditions by this anticipated closing date. The company has notified Nasdaq of its intention to delist its shares from the NASDAQ Global Select Market on that date or shortly thereafter.

09:08 EDT Grail enrolls first participant in study of Galleri multi-cancer detection test - Grail announced that the first participant has been enrolled in the REACH/Galleri-Medicare study at Community Health Network, an integrated healthcare system in central Indiana with more than 200 sites of care. The study is a first-of-its-kind real-world evidence study designed to further evaluate the clinical impact of the Galleri multi-cancer early detection test in Medicare beneficiaries. The study aims to enroll participants with a specific focus on inclusion of historically underrepresented communities, including seniors and people across diverse racial and ethnic minority groups, as well as socioeconomically disadvantaged and rural populations. The three-year study seeks to compare up to 50,000 Medicare beneficiaries who have received usual care plus an annual Galleri test with a comparator arm of beneficiaries who receive usual care without a Galleri test, across up to 50 study sites. The study is being conducted under an Investigational Device Exemption application approved by the FDA, and the Centers for Medicare and Medicaid Services' approval of the study for Medicare coverage.

09:07 EDT Wrap Technologies announces pilot with San Francisco Police Department - Wrap Technologies announced a pilot with the San Francisco Police Department. A recent San Francisco Police Commission meeting revealed that 60 of the Company's BolaWrap devices will be issued to the Field Training/Force Options Unit. This initiative has great potential to address the growing number of calls related to mental health issues and support the advancement of policing tactics. SFPD joins 50 California-based law enforcement agencies, including Hawthorne and Menlo Park Police Departments, that are advancing community policing with their decision to adopt de-escalation tools and training. Throughout July of 2024, SFPD will undergo comprehensive training at their Academy to master the use of the BolaWrap. This multi-day training program includes scenario-based sessions to build proficiency and confidence in deploying the device.

09:05 EDT General Mills announces Asheesh Saksena as Chief Strategy & Growth Officer - General Mills (GIS) announced Asheesh Saksena has been named Chief Strategy & Growth Officer, effective Aug. 26. He will report to Jeff Harmening, Chairman and CEO, join the Senior Leadership Team, and have global accountability for the company's comprehensive strategic planning process and for building long-term, sustainable plans and capabilities to accelerate growth. Saksena succeeds Dana McNabb, following her prior appointment to Group President, North America Retail. Saksena most recently served as Chief Growth Officer for Gap (GPS)where he was accountable for operations, technology, and the company's growth, portfolio and diversification strategy. Prior roles include President, Best Buy Health, and Chief Strategic Growth Officer, Best Buy Co., Inc., in addition to Chief Strategy Officer for Cox Communications and Deputy Chief Strategy Officer, Time Warner Cable.

09:04 EDT Amazon announces record Prime Day - Amazon announced that Prime Day was Amazon's biggest Prime Day shopping event ever, with record sales and more items sold during the two-day event than any previous Prime Day event. Millions more Prime members shopped the two-day shopping event compared to Prime Day 2023.

09:03 EDT LPL Financial: Stable Wealth joins LPL's broker-dealer, RIA, custodial platforms - LPL Financial announced that financial advisor Alex Williams, CFP, has joined LPL Financial's broker-dealer, RIA and custodial platforms to launch a new independent practice, Stable Wealth. He reported serving approximately $170 million in advisory, brokerage and retirement plan assets and joins LPL from Edward Jones. Based in Olympia, Wash., Williams is a 25-year veteran of the financial services industry and past regional leader who enjoys putting the investment strategies and comprehensive financial plans in place to help clients take more control of their financial journey. He works primarily with retirees and clients in the equestrian community, where his wife, Jennifer, has won numerous accolades and a National Championship in dressage at the highest Grand Prix level.

08:59 EDT Domino's Pizza sees Q3 same-store sales growth 'slightly below' Q2 rate - Sandeep Reddy, Domino's Pizza Chief Financial Officer, said on the company's earnings call: "Specific to Q3, we expect comps to be slightly below what we saw in Q2 on a one-year basis. We're expecting one less boost week, partially offset by a continued ramp in the world. Second seems to be able to increase the marketing and awareness grow. And we are expecting to exit the year with an overall sales mix of 3% or more third, international comps to accelerate to 3% or more long-term guidance in the back half of the year. As also noted, we now expect to fall below 1,100 or more net new store number for 2024. This is due to challenges in our international business... We will provide an update on the impact to our long-term outlook for 2025 and beyond. We continue to expect an 8% or more year-over-year increase in operating income, excluding the impact of foreign currency. To highlight some of the components for the full year, you can expect operating income margins to be relatively flat compared to 2023 and to be down slightly in Q3. As a reminder, we are not expecting to see cost leverage in 2024, primarily due to investments we are making in consumer technology, store technology and supply chain capacity to support future sales group."

08:51 EDT Brenmiller Energy to expand bGen capabilities for AI data center cooling - Brenmiller Energy announced that it will expand its proprietary technology's capabilities and develop a Cold Thermal Energy Storage or CTES, solution for data center applications, called the bGen Cool. The Company will continue bGen production for power-to-heat applications in service of its current commercial opportunities, valued at up to $500M in potential sales. The rapid integration of artificial intelligence computing into enterprise systems is driving unprecedented demand for power. According to a study published by the International Energy Agency in January 2024, it requires almost 10x more electricity to process a ChatGPT query than it does to run a typical Google search. A note published by Goldman Sachs research in May 2024 estimates that data center power demand will increase by more than 160% by 2030, growing from 1-2% to 3-4% of all power consumption worldwide and creating considerable upstream opportunity for innovation and investment in cooling and energy efficiency technologies. Leveraging the bGen's core competencies, Brenmiller expects minimal investment is needed to adapt its existing proprietary TES technology to meet data center demand.

08:48 EDT SEM chooses Conduent to 'transform public transport network' ahead of Olympics - Conduent Transportation, a global provider of smart mobility technology solutions and business unit of Conduent announced that Saint-Etienne Metropole SEM , the public transportation authority for the city of Saint-Etienne and its surrounding metropolitan area in east-central France, has selected Conduent for a three-phase transformation of its STAS bus and tram network. SEM serves a population of more than 400,000. ..Saint-Etienne tram, credit: STASIn phase one, Conduent implemented an open payment system that allows passengers, on all of the network's lines, to pay using validators installed on buses and trams. Payments can be made with contactless EMV debit and credit cards, and NFC-enabled digital wallets such as Apple Pay, Google Pay and Samsung Pay. More than 300 validators were installed in this first phase, with one on each bus and at least two on each tram, in time for Saint-Etienne to play its role as a host city for the Summer Olympic Games.

08:43 EDT Kopin gets production validation and final milestone for new OLEDoS display - Kopin Corporation announced that it has achieved the final milestone in the production qualification of its high performance Organic Light Emitting Diode on Silicon or OLEDoS, display for Collins Aerospace's F-35 Lightning II Helmet Mounted Display System or HMDS. "Production validation for the new OLEDoS display is the final milestone in the qualification of our display and confirms the exceptional performance of our OLEDoS technology," stated Bill Maffucci, the Company's Vice President of Business Development and Strategy. "This display is designed to meet higher performance requirements than the interim OLEDoS displays currently being procured by the program, and as a result the Kopin OLEDoS is the only version moving forward into final qualification and full rate production. This successful completion of customer testing will enable Kopin to continue as the sole provider of production displays for the F-35 HMDS through two generations of display technologies."

08:40 EDT Clarus appoints three strategic hires for its Adventure segment - Clarus has made three important strategic hires for its Adventure segment in order to accelerate growth in the U.S. and international markets and strengthen its global OEM initiatives. Adventure, comprised of Rhino-Rack, MAXTRAX, and TRED Outdoors, has appointed Tripp Wyckoff to the role of General Manager of the Americas, David Cook as Global Head of OEM and Daniel Bruntsch as Head of EMEA Sales.

08:38 EDT Lucas GC, 4Paradigm sign strategic cooperation agreement - Lucas GC announced that it has signed a strategic cooperation agreement with Beijing Fourth Paradigm Technology to develop Artificial Intelligence training programs. The two companies will work together to develop training courses in artificial intelligence, machine learning, and big data analytics. Howard Lee, Founder and CEO of Lucas, said, "As the applications of AI proliferate, the demand for AI talents has increased significantly. However, the industry lacks practical and relevant AI training opportunities with knowledge that can be immediately applied on the job. In cooperation with 4Paradigm, Lucas will leverage both companies' resources in granted patents, practical on-the-job training materials that are relevant to real-life scenarios, to jointly develop AI training courses that can equip AI professionals with skills that the industry needs. Our training courses will focus more on practical industry applications rather than theoretical learning, which we believe is well covered in schools. Our collaborative efforts aim to close the gap between academia and industry, ensuring that graduates possess the practical AI skills required by organizations to improve their employability. Given China is leading in AI applications worldwide, we believe the contents with practical industry knowledge can be applicable to other geographies as well, in line with Lucas' overseas expansion roadmap."

08:36 EDT Intuitive Machines finalizes landing site for IM-2 lunar prospecting mission - Intuitive Machines has finalized the IM-2 mission landing region ahead of its sold-out IM-2 mission. The IM-2 mission is designed to prospect for water ice and other volatiles on the Moon's south pole, which requires a landing site that supports the high probability of ice stability within one meter of the lunar surface. Working with NASA, Intuitive Machines selected a 200-meter diameter elliptical region on the Shackleton Connecting Ridge with favorable terrain, Earth communications position, and solar angles for power generation. To align with the landing site's solar power conditions, the mission must be timed between November 2024 and January 2025, IM-2 is currently planned for late 2024. This selection finalized the previously announced pending task order with NASA.

08:35 EDT Scorpius executes first cGMP microbial batches at San Antonio facility - Scorpius announced the successful execution of its first current Good Manufacturing Practice, cGMP, microbial batches at its San Antonio manufacturing facility. This significant milestone marks the beginning of Scorpius' support for manufacturing programs through clinical manufacturing, with aspirations for future commercial activities. Scorpius' facilities have already attracted significant interest, resulting in a substantial backlog of client program bookings. Jeff Wolf, CEO of Scorpius Holdings, remarked, "We are thrilled to have successfully completed our first cGMP microbial batches at the San Antonio facility. This milestone is a result of the dedication and collaboration among Scorpius' manufacturing, process development, quality, and operations teams. The successful execution is a testament to the robust systems we have built and marks another step forward in our commitment to U.S. based cGMP activities for both current and future Scorpius clients."

08:35 EDT Nexalin selected to join Breaking Barriers to Substance Use Recovery coalition - Nexalin Technology has been selected to serve as a founding member of Breaking Barriers to Substance Use Recovery, a coalition of major industry participants and preeminent healthcare providers. Established as a tax-exempt organization, Breaking Barriers to Substance Use Recovery is focused on identifying and dismantling the obstacles to effective treatment for opioid use disorder. Breaking Barriers to Substance Use Recovery brings together bringing together a broad cross section of leaders in the medical and science and technology industries to develop and formulate pioneering and innovative solutions to combat the opioid crisis. The organization also advocates for the adoption of comprehensive policy solutions in support of its critical life-saving objectives and raises public awareness through education campaigns. Breaking Barriers to Substance Use Recovery is a pioneering 501(c)(4) organization dedicated to identifying and dismantling the obstacles to effective treatment for opioid use disorder through advocacy, especially in veteran and rural communities across the United States, for policy solutions and public educational campaigns that support these critical life-saving objectives.

08:33 EDT DriveItAway partners with Corporate Claims Management for vehicle services - DriveItAway Holdings has partnered with Corporate Claims Management to directly manage all vehicle services, including maintenance, mechanical repairs and body shop repairs, allowing it to scale its company-owned fleet rapidly, following its new vehicle financing announced in May.

08:32 EDT Microbot Medical completes enrollment of sites in human clinical trial - Microbot Medical announces it has received Institutional Review Board, IRB, approval and signed a clinical trial agreement with Memorial Sloan Kettering Cancer Center, located in New York City, New York. Memorial Sloan Kettering Cancer Center will conduct the clinical trial as part of the Investigational Device Exemption for LIBERTY, and the Company expects its results will support the future marketing submission to the FDA and subsequent commercialization. "We are excited to have a hospital the caliber of Memorial Sloan Kettering Cancer Center partnering with us to complete the enrollment of the clinical sites in our trial," commented Harel Gadot, CEO, President and Chairman of Microbot Medical.

08:31 EDT Intelligent Bio Solutions advances on 510k pathway with biocompatibility study - Intelligent Bio Solutions announced the successful completion of biocompatibility testing of its Intelligent Fingerprinting Drug Screening System, a pivotal phase in the clinical study plan required for FDA 510(k) regulatory clearance. The biocompatibility study, conducted in accordance with ISO 10993 standards, involved a thorough evaluation of the system's materials that come into contact with human skin. With the successful completion of the biocompatibility study, INBS has confirmed that all materials used in its system, including the Drug Screening Cartridge, Confirmatory Cartridge and the DSR-Plus Reader, are safe for use in medical devices. Harry Simeonidis, President and CEO at INBS, commented, "This milestone is an important element of our FDA 510(k) pathway for regulatory clearance, and we are proud to announce its completion. Our development team continues to execute on our plan to meet FDA requirements for our Drug Screening System. We are now poised to move forward with the next stages of our clinical study plan and move closer to bringing our innovative technology to the market."

08:23 EDT Allstate sees estimated catastrophe losses for the month of June of $230M - The Allstate Corporation announced estimated catastrophe losses for the month of June of $230M or $182M, after-tax. June month catastrophe losses include 18 events estimated at $274M, primarily related to geographically widespread wind and hail events. Total catastrophe losses for the second quarter were $2.12B , pre-tax or $1.67B, after-tax, and total catastrophe losses for June year-to-date were $2.85B, pre-tax, or $2.25B , after-tax.

08:23 EDT NKGen Biotech to present new biomarker data on SNK01 - NKGen Biotech announced that it will present new biomarker data on SNK01 in Alzheimer's disease during a poster presentation at the upcoming Alzheimer's Association International Conference, AAIC, to be held in Philadelphia, PA at the Pennsylvania Convention Center and online from July 28 - August 1, 2024.

08:19 EDT Biora Therapeutics announces data from Phase 1 trial of BT-600 - Biora Therapeutics presented supplemental data from the Phase 1 trial of BT-600 during the company's virtual KOL event on Wednesday, July 17, 2024. BT-600, an orally administered drug-device combination, is in development for the treatment of patients with ulcerative colitis. BT-600 leverages Biora's ingestible NaviCap device to deliver a proprietary liquid formulation of tofacitinib directly to the colon. SUMMARY OF KEY BT-600 PHASE 1 TRIAL RESULTS: Results from the Phase 1 clinical trial demonstrate a pharmacokinetic profile consistent with drug delivery and absorption in the colon for both single and multiple ascending dose cohorts: First evidence of systemic absorption of tofacitinib was at six hours, consistent with colonic delivery. Maximal levels in the trial occurred at eight to ten hours vs. 30 minutes for conventional oral tofacitinib in other trials. Maximal systemic drug exposure was three to four times lower than that seen with conventional oral tofacitinib in other trials, demonstrating the NaviCap platform's ability to deliver locally to the colon and limit systemic drug exposure. The distribution of colon tissue exposure suggests that pan-colonic delivery of tofacitinib was achieved: Sites in the distal colon were biopsied, following delivery of tofacitinib in the proximal colon. Biopsy results provided evidence of drug exposure extending to the distal colon, at common sites of disease. Modeling projects tissue levels at or above the estimated IC90 through at least 16 hours after dosing. Post-retrieval device analysis further confirmed that NaviCap devices accurately delivered drug in the colon, with no early release, and with greater than95% of devices detecting colon entry. NaviCap devices were well tolerated by participants in both the SAD and MAD cohorts: All AEs were mild and consistent with those expected in a healthy population. No evidence of device or drug colon toxicity; colon tissue histology was within normal limits. There were no notable changes or differences in safety laboratory parameters between groups.

08:17 EDT Armlogi Holding announces significant expansion of trucking operations - Armlogi announced the substantial expansion of its trucking department through increased staffing, enhanced equipment, and extended services. This strategic expansion aims to double the trucking volume and extend specialized services to major clients, including Amazon, to address the growing demands of the e-sports logistics industry and other key market sectors. "Our expansion is not just about scaling up," said Aidy Chou, Chairman and Chief Executive Officer of Armlogi. "It's about strategically enhancing our capabilities to deliver personalized, timely, and professional services that meet the evolving needs of our customers. With these improvements, we believe we are setting a new logistics efficiency and customer satisfaction standard." Looking forward, Armlogi plans to continue its growth trajectory with further investments in technology and infrastructure, aiming for an increase in transportation assets by the end of the year.

08:16 EDT NV5 Global awarded $10M by USGS for geospatial projects - NV5 Global announced that it has been awarded $10 million by the U.S. Geological Survey, USGS, to provide geospatial services for improved resource management. "The expanding role of geospatial data in water and natural resource management, utility infrastructure reliability, national security, and economic stability continues to drive growth in the demand for geospatial data management and analysis," said Dickerson Wright, PE, Executive Chairman of NV5. "As the leading geospatial data analytics provider, NV5 is pleased to support USGS initiatives that contribute to the responsible management and identification of critical natural resources across the nation." NV5 was awarded a $3 million contract by the USGS to analyze existing mineral deposits and identify new occurrences over 11,500 square miles in Western Texas. NV5 was also awarded a $6 million contract by the USGS for lidar collection and processing of over 8,500 square miles in Alaska that will help enhance forest resource management, monitor coastal erosion, support community resilience efforts, and safeguard infrastructure for local communities. The USGS has also awarded NV5 a $1 million contract to integrate geospatial elevation data into the 3D Hydrography Program to enhance understanding of Alaska's bodies of water and facilitate informed resource management across the state.

08:14 EDT Cocrystal Pharma reports results from SAD cohorts of Phase 1 study with CDI-988 - Cocrystal Pharma reported favorable safety and tolerability results from the single-ascending dose, SAD, cohorts of the Phase 1 study in healthy volunteers with CDI-988, its potent, oral, pan-viral protease inhibitor. CDI-988 was specifically designed and developed using Cocrystal's proprietary structure-based drug discovery platform technology as a broad-spectrum antiviral inhibitor to a highly conserved region in the active site of 3CL viral proteases. It is being developed as the first dual, broad-spectrum antiviral for the treatment of norovirus and coronaviruses.

08:11 EDT authID, FinClusive enter partnership to integrate biometric, FCC solutions - authID and FinClusive Capital, a global provider of comprehensive financial crimes compliance, FCC, and digital identity tools, announced a new partnership. Under this agreement, authID's biometric services will be integrated into FinClusive's Compliance-as-a-Service platform to help combat the rapidly escalating threat of financial crimes, identity fraud, malicious, AI-driven deepfakes and other illicit finance, fraud, and related vulnerabilities. The FinClusive platform enables secure and compliant access to essential financial services by both traditional and alternative financial services organizations worldwide. To service its customers with an international client base, FinClusive needed a best-in-class, global identity provider of enhanced identity verification for onboarding and ongoing monitoring. authID's automated identity document authentication covering over 13,000 U.S. and international government-issued ID documents made it the ideal solution for streamlining and securing digital onboarding and ongoing authentication across FinClusive's customer portfolio, while delivering the essential privacy controls expected within digital channels.

08:09 EDT Enphase Energy launches new home energy systems in Luxembourg - Enphase Energy announced the launch of its most powerful Enphase Energy System to-date, featuring the new IQ Battery 5P and IQ8 Microinverters, for customers in Luxembourg. The new Enphase Energy System with the IQ Battery 5P offers a significantly improved experience for homeowners and installers. It enables configurations ranging from 5 to 60 kWh with more power, resilient wired communication, and an improved commissioning experience. Enphase IQ Batteries come with a 15-year warranty when activated in Luxembourg.

08:07 EDT Twist Bioscience says first patient dosed in Pure Biologics' BA-0405 study - Twist Bioscience announced that the first patient has been dosed in Pure Biologics' exploratory Phase 0 clinical study of PBA-0405. PBA-0405 is a fully human IgG1 antibody that was discovered using Twist Biopharma Solutions' synthetic antibody phage display libraries. Twist Biopharma Solutions, a division of Twist Bioscience, provides an integrated offering of in vitro, in vivo, and in silico tools for antibody discovery research. This exploratory study is designed to provide early insights into the biological effects of PBA-0405 within the tumor environment. "Solid tumors are historically difficult for drug developers to target and treat. This is the first antibody identified using our Twist Biopharma Solutions Library of Libraries to be tested in patients and it validates the potential of our synthetic antibody libraries to be used to discover novel drug candidates for hard-to-treat cancer indications," said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. "

08:07 EDT Haystack Oncology, Lisata Therapeutics initiate research collaboration - Haystack Oncology, a Quest Diagnostics (DGX) company, and Lisata Therapeutics (LSTA) announced a research collaboration. Lisata will deploy the highly sensitive Haystack MRD technology for the detection of circulating tumor DNA in a clinical study evaluating certepetide plus chemotherapy as an investigational treatment for metastatic pancreatic cancer. In the FORTIFIDE study, Lisata is investigating the safety, tolerability, and efficacy of its lead product candidate, certepetide, when given as a 4-hour continuous infusion in combination with standard-of-care treatment in subjects with metastatic pancreatic ductal adenocarcinoma who have progressed on FOLFIRINOX, a treatment for pancreatic cancer. As part of this research, Lisata has engaged Haystack to use its MRD technology to measure serum ctDNA levels at multiple timepoints in patients throughout the study as an exploratory endpoint for analyzing the early therapeutic effect of certepetide. Certepetide is an investigational drug designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate solid tumors more effectively.

08:06 EDT Ford invests $3B to expand Super Duty production, to assemble in Canada in 2026 - Ford announced plans to assemble F-Series Super Duty pickups at its Oakville Assembly Complex in Ontario, Canada, starting in 2026. The move to add production of up to 100,000 units of its Super Duty to Oakville expands Super Duty production across three plants in North America, including Kentucky Truck Plant and Ohio Assembly Plant, which are operating at full capacity. It also paves the way to bring multi-energy technology to the next generation of Super Duty trucks. In total, Ford plans to invest approximately $3B to expand Super Duty production, including $2.3B to install assembly and integrated stamping operations at Oakville Assembly Complex. When complete, Oakville Assembly Complex will be a fully flexible plant. Boosting Super Duty assembly will initially secure approximately 1,800 Canadian jobs at Oakville Assembly Complex, 400 more than would initially have been needed to produce the three-row electric vehicle. Unifor-represented employees at Oakville Assembly Complex will return to work in 2026, a full year earlier than previously planned. The increased production also adds approximately 150 jobs at Windsor Engine Complex, which will manufacture more V8 engines for Super Duty. Ford plans to hire new employees and add overtime at U.S. component plants that support Super Duty production.

08:05 EDT Southern California Bancorp, California BanCorp receive merger approval - Southern California Bancorp (BCAL) and California BanCorp (CALB) announced that at meetings of their respective shareholders held on July 17, 2024, Southern California Bancorp and California BanCorp shareholders approved the merger of California BanCorp with and into Southern California Bancorp, with Southern California Bancorp the surviving corporation pursuant to the Merger Agreement, dated January 30, 2024, by and between Southern California Bancorp and California BanCorp. Shareholders of Southern California Bancorp also approved a change of the company's name from Southern California Bancorp to California BanCorp and an amendment to Southern California Bancorp's bylaws to change the allowable range of members of the board of directors to seven to 13, from its previous range of six to 11. The merger has received all required regulatory approvals and is expected to close on July 31, 2024.

08:03 EDT Hesai selected by Baidu as exclusive long-range lidar provider - Hesai (HSAI) has been selected by Baidu (BIDU) to be the exclusive long-range lidar supplier for its next-generation robotaxi platform Yichi 06. According to industry analysts, this lidar deal is worth an estimated $200M-$300M based on Baidu's plans to deploy 100,000 robotaxi vehicles in China. It's expected to be the first widespread application of robotaxi in the Chinese market. The sixth generation of Baidu's robotaxi is undergoing road testing in Wuhan. Hesai's total lidar shipment volume has exceeded 380,000 units as of the first quarter of this year.

08:02 EDT Phathom Pharmaceuticals announces FDA approval of VOQUEZNA - Phathom Pharmaceuticals announced today the U.S. Food and Drug Administration, FDA, has approved VOQUEZNA 10 mg tablets for the relief of heartburn associated with Non-Erosive Gastroesophageal Reflux Disease in adults. Non-Erosive GERD represents a substantial segment of the U.S. GERD population, affecting millions of individuals suffering from frequent heartburn. This is the third FDA approval for VOQUEZNA, which is also approved to treat all severities of Erosive Esophagitis, also referred to as Erosive GERD, and in combination with antibiotics for the eradication of Helicobacter pylori infection. VOQUEZNA met its primary endpoint in its Phase 3 pivotal trial by demonstrating a significant and rapid reduction of heartburn with daily treatment. VOQUEZNA represents the first major innovation in GERD treatment in over 30 years and the only FDA-approved treatment of its kind available in the U.S.

08:00 EDT BriaCell reports 'significantly higher' PFS for patient in study of Bria-IMT - BriaCell Therapeutics reports significantly higher PFS for its top responder patient in the Phase 2 study of BriaCell's Bria-IMT regimen in combination with an immune checkpoint inhibitor in metastatic breast cancer. The patient remains alive and she continues to receive BriaCell's treatment regimen. The patient had a large right orbital lesion and a right temporal lobe lesion. The temporal lobe lesion is no longer detectable, while the orbital lesion has continued to shrink markedly. In addition, her tumor markers have markedly decreased from her pre-treatment levels.

07:50 EDT - Lifeway Foods shareholders Ludmila and Edward Smolyansky, who beneficially own approximately 29% of Lifeway, released a letter and presentation detailing their belief about certain directors' history of breaches of fiduciary duty, mismanagement of company assets, and history of underperformance, while calling for the resignation and replacement of lead director Jason Scher, Directors Pol Sikar, Jody Levy, Dorri McWhorter, Perfecto Sanchez and CEO/Chairperson Julie Smolyansky. The letter seeks for a new independent Board to be comprised of up to 8 members, including past Director and Co-Founder Ludmila Smolyansky, as well as an invitation to current and past Director Juan Carlos Dalto and calls for the immediate tTermination of Lifeway Foods Corporate Representative and Julie Smolyansky's "Chief of Staff" and Spouse, Jason Burdeen, a former jeweler, whom is believed to be acting as the defacto CEO and General Counsel of Lifeway. The letter also calls for the adoption of an anti-nepotism policy to the bylaws and for an operational and strategic review of the business.Reference Link

07:38 EDT SunCar Technology signs two-year service agreement with China Merchants Bank - SunCar Technology has been selected as the provider of concierge car services for China Merchants Bank in China. This two-year service framework agreement represents a milestone in the collaboration between SunCar and CMB. This new partnership will see SunCar delivering comprehensive concierge car services to CMB's private banking clients.

07:37 EDT Bowman acquires professional services firm FCS, sees immediate accretion - Bowman Consulting Groupannounced the acquisition of Redmond, Washington based FCS Group. FCS is a professional services firm focused on addressing the financial, management and economic challenges facing public sector entities including utilities, state and local governments, regional agencies and public safety organizations. Led by current President and Principal John Ghilarducci, FCS specializes in utility rate and fee advisory services along with utility management, financial and economic planning and infrastructure funding consulting. FCS consults for a variety of clients, including government agencies in urban and suburban areas, rural utility systems, municipal authorities in regions with seasonal or climate sensitivities and communities with special commercial and industrial needs. "FCS immediately expands our reach and our resume within the utility, government and sustainability markets," said Gary Bowman, chairman and CEO of Bowman. "This acquisition, while not a typical engineering firm, presents a unique opportunity both to accelerate our penetration of the utility and renewables markets and to expand the breadth of services we can offer our existing portfolio of traditional utility and energy transition clients. FCS also brings to Bowman a substantial history of successful public sector engagements. I am confident that the combination of our combined utility services experiences and long-standing client relationships will deliver meaningful revenue synergies as we integrate our organizations. I am excited to have John and the entire FCS team become part of Bowman." Financed with a combination of cash, seller notes and equity, the acquisition falls within previously discussed target multiples and operating metric ranges. The Company anticipates the acquisition will initially contribute at an annualized net service billing run rate of approximately $7M and be immediately accretive. More detailed information on M&A activities, pipeline and guidance updates are provided in connection with scheduled quarterly and annual communications.

07:34 EDT Orezone Gold reports Q2 Bombore gold production of 25,524 ounces - Orezone Gold announced its second quarter 2024 gold production results from its Bombore Gold Mine: Gold production of 25,524 ounces; Gold sales of 24,937 ounces at an average realized price of $2,334/oz, resulting in sales of $58.2 million. Patrick Downey, President & CEO stated, "Q2 marked a solid operating quarter and was consistent with our annual plan, despite experiencing regional grid power interruptions earlier in the quarter. As previously guided, Q2 was scheduled to be the lowest grade quarter in 2024 as the result of mine sequencing. With access to the higher-grade oxides in the southern half of the concession now established, Orezone reiterates its 2024 production guidance of 110,000 to 125,000 ounces." Orezone continued to advance early works and front-end engineering for the Bombore Phase II hard rock expansion throughout the second quarter. Subsequent to quarter-end, the Company announced that it has secured binding commitments totaling over $105M to fully finance the construction of the hard rock expansion, which will see annual gold production increase to over 170,000 ounces in 2026, an approximate 50% increase from current levels.

07:30 EDT Genentech announces two-year data from Pagoda, Pavilion studies - Genentech, a member of the Roche, announced two-year data from the Phase III Pagoda and Pavilion studies evaluating Susvimo 100 mg/mL for the treatment of diabetic macular edema, or DME, and diabetic retinopathy, or DR, respectively, the two leading causes of vision loss in adults with diabetes. Susvimo is the first and only refillable eye implant that provides continuous delivery of a customized formulation of ranibizumab via the Port Delivery Platform. The results build on the primary one-year analyses of the Pagoda and Pavilion studies, with Susvimo demonstrating sustained efficacy over two years and safety consistent with the known safety profile for Susvimo in people with DME and DR. Detailed results were presented at the American Society of Retina Specialists 2024 annual meeting in Stockholm, Sweden. Additionally, the FDA has accepted Genentech's supplemental biologics license application, or sBLA, for Susvimo for the treatment of DME and DR. The filing acceptance is based on the one-year results from the Phase III Pagoda and Pavilion studies, which showed that both studies met their primary endpoint. To date, Susvimo is approved in the U.S. for the treatment of wet, or neovascular, age-related macular degeneration, or AMD. Treatment for DME typically involves regular eye injections every one to four months. In Pagoda, people with DME who received Susvimo refilled every six months achieved non-inferior visual acuity gains compared with those receiving monthly 0.5 mg ranibizumab intravitreal injections. Approximately 95% of patients treated with Susvimo did not need additional treatment with supplemental injections during the primary analyses study period. In Pavilion, people with DR who received Susvimo refilled every nine months achieved superior improvements on the Diabetic Retinopathy Severity Scale, or DRSS, compared with participants under monthly clinical observation. No individuals treated with Susvimo needed additional treatment with supplemental injections during the primary analyses study period, compared to 60% in the control arm. In Pagoda, people with DME receiving Susvimo refilled every six months through approximately two years continued to maintain improvements in vision gains seen at one year. A gain of 9.8 eye chart letters is similar to gaining two more lines on an eye chart. Approximately 95% of individuals did not need additional treatment with supplemental injections. Anatomically, Susvimo showed sustained improvements in central subfield thickness through week 112. Reduction in CST, a measure of retinal drying, is an indicator of swelling from fluid in the back of the eye caused by unstable, leaky blood vessels. The safety data were consistent with the known safety profile for Susvimo in people with DME, with no new safety signals observed. In people treated with Susvimo, no cases of endophthalmitis were reported up to one year and the rate of endophthalmitis through week 112 was 0.7%, compared to 0.8% in the control arm. Refills of Susvimo were resumed in affected participants after successful resolution of endophthalmitis. In Pavilion, people with DR receiving Susvimo refilled every nine months through approximately two years maintained DRSS improvements seen at one year. Specifically, at week 100, 80% of Susvimo participants achieved a two-step or greater improvement on the DRSS from pre-implant baseline, and participants who received Susvimo from week 64 either maintained or improved their DRSS score from pre-implant baseline. A two-step or greater improvement in the DRSS is a clinically relevant measure of the decrease in risk for developing vision-threatening complications secondary to diabetes. Approximately 98% of participants treated with Susvimo did not need additional treatment with supplemental injections. The safety data were consistent with the known safety profile for Susvimo in people with DR, with no new safety signals observed. In people treated with Susvimo, no cases of endophthalmitis were reported up to one year and the rate of endophthalmitis through week 100 was 0.8%. One participant with DR developed endophthalmitis and continued receiving treatment with Susvimo refills after successful resolution.

07:12 EDT Bruker posts bond in Germany to suspend injunction hurting sales of CosMx SMI - Bruker announced that it has posted a bond, as authorized by the Munich Higher Regional Court, in order to suspend an injunction that had been impacting sales of CosMx Spatial Molecular Imager SMI products by its NanoString business in Germany. This development is connected with ongoing patent litigation with 10x Genomics, during an appeal process in Germany. Effective immediately, all CosMx products are once again available to German scientific instrument customers. In December 2023, the German Higher Regional Court of Munich cited concerns with the lower Munich Regional Court's May 2023 decision and granted NanoString the right to have the injunction on sales of CosMx products in Germany lifted, subject to payment of a bond. The Munich Higher Regional Court ruled that suspending enforcement of the injunction was appropriate, since the lower court had failed to address aspects of the case that were relevant to the decision. The Court observed that a disputed feature of the patent at issue was seemingly overlooked by the lower court. "We are thrilled that our customers in Germany have regained access to our full suite of products for the CosMx instrument, with the highest functionality of any imager available in the spatial transcriptomics market," said Todd Garland, President of the NanoString division

07:11 EDT Interactive Strength says Gold's Gym installs CLMBRs in three locations in Texas - Interactive Strength announced that, following last month's six-figure order from Gold's Gym SoCal, Gold's Gym is installing CLMBRs in three of the brand's 58 locations in Texas. Trent Ward, Co-Founder and CEO of TRNR, said, "We have high expectations for future growth in the Gold's Gym system due to the six-figure flagship CLMBR order for the 23 locations of Gold's Gym SoCal that we announced at the end of June. Today's announcement of the installations of multiple CLMBRs in three Gold's Gym locations in Central Texas during July and August is a great next step in penetrating the larger Gold's Gym system. We hope to expand CLMBR installations to the other 55 Gold's Gym locations in Texas and then to more of Gold's Gym's 600 plus locations."

07:10 EDT Flyht Aerospace's CrossConsense secures contracts for aircraft data migration - FLYHT Aerospace Solutions' CrossConsense has secured two new contracts, demonstrating the growing demand for its MRO services offering. The first contract is an expansion of CrossConsense's relationship with a leading management consultancy, first announced in September 2023, in which CrossConsense is managing an aircraft data migration project for one of the consultancy's airline clients, a large flag carrier in Europe. The second contract is with a global leader in the logistics industry, specializing in international shipping, courier services and transportation. CrossConsense has been chosen to collaborate on the design phase of a large data migration project for the company, which may evolve to future phases, implementation and other services. The combination of these two contracts is valued at approximately EUR 300,000, expected to be delivered by the end of 2024.

07:08 EDT Lifeist Wellness' Mikra unveils Big Summer Sale - Lifeist Wellnessreports that its U.S. biosciences subsidiary Mikra Cellular Sciences has unveiled its Big Summer Sale, with a free gift included with every order while supplies last. The sale is on now, and customers are invited to shop at https://wearemikra.com/collections/shop-page-collection to receive their free gift. Mikra is in the midst of a ground-up rebuild of our marketing and sales strategy to better meet the moment in 2024, and we look forward to sharing more details of that new direction with our customers, shareholders and other stakeholders in the near future.

07:07 EDT Li-Cycle appoints Craig Cunningham CFO - Li-Cycle (LICY) announced that it has appointed Craig Cunningham to the role of CFO, effective July 20. Cunningham has served as Li-Cycle's interim CFO since March. As CFO, he will continue to lead the company's finance function, supporting Li-Cycle's operations and strategic priorities. Before joining Li-Cycle, Cunningham was CFO at Electra Battery Materials (ELBM).

07:07 EDT Lee Enterprises appoints McIntosh, Miller to board - Madeline McIntosh and Jon Miller have joined the board of directors of Lee Enterprises, Incorporated. They fill retirement vacancies, bringing the board back to nine members. In March 2024, she launched Authors Equity, a book publisher dedicated to a reshaped relationship with authors and publishing talent. Miller has been president and CEO of USA Interactive for the past eight years.

07:05 EDT LuxUrban Hotels announces full exercise of over allotment option - LuxUrban Hotels announced that the underwriter of its underwritten public offering has exercised its over-allotment option in full to purchase an additional 4,500,000 shares of the Company's common stock at the public offering price of $0.17 per share. After giving effect to the full exercise of the over-allotment option, the Company sold 34,500,000 shares of its common stock for aggregate gross proceeds of $5,865,000, before underwriting discounts and commissions and estimated offering expenses payable by the Company. Alexander Capital, L.P. acted as sole book-running manager for the offering. The Company intends to use the proceeds from the offering for working capital and other general corporate purposes.

07:04 EDT Universal Stainless & Alloy reaches 5-year agreement at North Jackson facility - Universal Stainless & Alloy Products reported today that it has reached a new five-year collective bargaining agreement covering the hourly production and maintenance employees at its North Jackson facility represented by Local Unit 2332-2 of the United Steelworkers. Christopher Zimmer, President and Chief Executive Officer, commented: "We are pleased to have successfully reached this new labor agreement, which is in the best interests of our employees, customers and shareholders. The capabilities of our North Jackson facility, and the capital investments we have made there, have an essential role in our transformational growth strategy."

07:04 EDT Wayfair announces Black Friday in July sale - Wayfair is celebrating Black Friday in July with four days of exclusive sales, including flash deals that drop every 24 hours and limited quantity doorbusters at jaw-dropping prices across brands like Blackstone, Cuisinart, GE, and Sealy. Beginning July 26 at midnight ET, shoppers can save on everything they need for their dream homes - from hosting essentials to home improvement, appliances to area rugs, and everything in between - with free shipping sitewide. Sales will run across Wayfair's family of brands, including AllModern, Joss & Main, and Birch Lane. Plus, Wayfair Professional members get Pro-exclusive deals on thousands of products. Customers can shop the sale online, on the Wayfair app, or in-person with unique deals at the new Wayfair store outside Chicago, IL and at all AllModern, Joss & Main, and Birch Lane retail stores. July 26-29, Wayfair shoppers can save up to 80% across all styles and categories.

07:02 EDT Canadian Solar's e-STORAGE awarded contract by Root-Power - Canadian Solar announced that e-STORAGE, which is part of the company's majority-owned subsidiary CSI Solar Co., Ltd., has been awarded a contract of 11 MW AC / 22 MWh AC energy storage solutions by Root-Power Ltd., part of the YLEM Group. The energy storage solutions will be used for Root-Power's Coryton Energy Park project, in Corringham, Essex, England. Construction of the project started in late May 2024. e-STORAGE and Root-Power have entered into an Energy Storage Supply Agreement and Long-Term Service Agreement. Root-Power plans to build over 1 GWh energy storage systems in the UK, over the next three to four years.

07:00 EDT Infosys reports Q1 EPS 18c, consensus 18c - Reports Q1 revenue $4.71B, consensus $4.65B. "We had an excellent start to FY25 with strong and broad-based growth, operating margin expansion, robust large deals, and highest ever cash generation. This is a testimony to our differentiated service offerings, enormous client trust, and relentless execution", said Salil Parekh, CEO. "With our focused approach for generative AI for enterprises working with their data sets on a cloud foundation, we have strong traction with our clients. This is building on our Topaz and Cobalt capabilities" he added.

06:48 EDT KeyCorp reiterates long-term targets - In the long term the company expects: positive operating leverage, cash efficiency ratio of 54%-56%, net charge-offs to average loans 40-60 basis points and ROTCE 16%-19%. Guidance taken from Q2 investor presentation slides.

06:41 EDT Nextdoor co-founder Sarah Leary returns to lead marketing - Nextdoor announced the return of co-founder Sarah Leary and former senior leader Kelsey Grady to the leadership team. Sarah will serve as Head of Marketing, Community, and Global Business Operations and Kelsey will serve as Head of Global Communications. Sarah and Kelsey's appointments follow the return of co-founder Nirav Tolia as CEO, as the team continues to focus on building the essential neighborhood network. As a co-founder of Nextdoor, Sarah Leary played a pivotal role in the inception, building, and scaling of Nextdoor from the beginning. Having previously served in senior leadership roles at eBay and Epinions, Sarah's drive to champion community paved the way for creating Nextdoor, which now has over 90M neighbors, in 335,000 neighborhoods across 11 countries. Sarah's experience as an investor, board member, and advisor to a diverse mix of consumer-facing companies will help catalyze Nextdoor's growth in this next phase.

06:37 EDT Bionomics initiates patient screening for the Phase 3 AFFIRM-1 trial - Bionomics announced the initiation of patient screening for the Phase 3 AFFIRM-1 trial evaluating the safety and efficacy of BNC210 for the acute, as-needed treatment of social anxiety disorder. Dr Papapetropoulos added, "We remain committed to advancing BNC210, a potential first- and best-in-class candidate with FDA Fast Track designation for both SAD and PTSD and look forward to sharing an update about our PTSD program following the recently completed EoPh2 meeting with the FDA."

06:35 EDT Snap-On sees 2024 CapEx $100M-$110M

06:11 EDT Domino's Pizza backs FY24-FY28 annual global sales growth view at least 7% - Backs FY24-FY28 annual income from operations growth view at least 8%. The company said, "The Company now expects the following on annual global net store growth:Global net store growth of 825 to 925 in 2024. U.S.: The Company continues to expect 175+ net stores annually for 2024 to 2028. International: The Company expects it will fall 175 to 275 stores below its 2024 goal of 925+ net stores in international primarily as a result of challenges in both openings and closures being faced by Domino's Pizza Enterprises ("DPE"), one of its master franchisees. The Company is partnering closely with DPE as they work through this process and will provide further updates once it has more visibility into the effect on its annual global net store growth numbers. The Company is temporarily suspending its guidance metric of 1,100+ global net stores until the full effect of DPE's store opens and closures on international net store growth are known."

06:08 EDT Westwater Resources signs graphite off-take sales agreement with Stellantis - Westwater Resources (WWR) announced the execution of a binding off-take agreement with Fiat Chrysler Automobiles or FCA, electric vehicle manufacturer and part of the Stellantis (STLA) group of companies. Westwater will supply natural graphite anode material from its Kellyton Graphite Plant located near Kellyton, Alabama, to FCA's battery partner plants located within the U.S. FCA will be obligated to purchase, on an annual basis, a quantity of product equal to a percentage of their forecasted volume.

06:06 EDT Brunswick announces comprehensive AI initiative - Brunswick is enhancing its ACES strategy with the announcement of Boating Intelligence, a comprehensive initiative to incorporate AI features into its products to deliver simpler, safer, smarter, and more sustainable boating. To accelerate its vision for Boating Intelligence, Brunswick Corporation is re-launching its I-Jet Lab at the University of Illinois Research Park. The newly named Boating Intelligence Design Lab, under the direction of Jeff Reifsnyder, is refocusing its programs on developing Brunswick's AI talent and capabilities, as well as supporting Brunswick's product development teams as they incorporate AI into Brunswick's next generation of products. BI DesignLab is already supporting the development of Brunswick's autonomous docking technology but is now also advancing work on AI-powered virtual agents, customized for marine applications, and other applications that will provide smart assistance to people operating their own boats and members of Brunswick's Freedom Boat Club.

06:03 EDT Boehringer Ingelheim, GoodRx enter exclusive patient affordability initiative - Boehringer Ingelheim and GoodRx announced a patient affordability initiative to provide citrate-free Adalimumab-adbm, Boehringer's biosimilar to Humira, at a low cash price available exclusively on GoodRx. This program is a significant step in addressing access and affordability in one of the largest therapeutic categories with a high-cost burden for patients. Beginning immediately, Boehringer and GoodRx are offering prices for both high-concentration and low-concentration citrate-free formulations of Adalimumab-adbm as a pre-filled syringe or autoinjector at an exclusive cost of $550 per two-pack, which represents a 92% discount from the Humira list price.

05:29 EDT Nokia sees FY24 comparable operating profit EUR 2.3B-EUR 2.9B - Sees FY24 free cash flow 30%-60% conversion from comparable operating profit.

05:18 EDT Clarivate partners with OhioLINK, SearchOhio to develop library experience - Clarivate announced a partnership with OhioLINK, Ohio's academic library consortium, and SearchOhio, a consortium of Ohio public libraries, to develop a new library resource sharing consortial experience. Through this partnership Clarivate will unify OhioLINK and SearchOhio's resource sharing platforms to enhance library user experiences and services, improve operational efficiencies and build upon existing consortia collaboration. The new solution is expected to be implemented by mid-year in 2025.

05:13 EDT GE HealthCare to buy AI software business from Intelligent Ultrasound for $51M - GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC's clinical artificial intelligence software business for total consideration of approximately $51M. Intelligent Ultrasound is specializes in integrated AI-driven image analysis tools designed to make ultrasound smarter and more efficient. GE HealthCare plans to incorporate these solutions across the ultrasound portfolio. By acquiring this business, GE HealthCare also adds an AI innovation pipeline that serves to help advance future development and realize long-term efficiencies. The consummation of the transaction is subject to customary closing conditions and is expected to close in Q4. Additional details of the transaction have not been disclosed publicly. GE HealthCare intends to fund this transaction with cash on hand.

05:05 EDT Lilium announces Saudia Group to buy 50 jets with option to buy 50 more - Saudia Group and Lilium signed a binding sales agreement for 50 Lilium Jets, with options for the purchase of 50 more. The ceremony was held at Lilium's HQ in Gauting near Munich. The contract was signed by Fahd Al-Jarbou, CEO of Saudia Private, representing Saudia Group, and Lilium's CEO Klaus Roewe. This sales agreement, which follows the memorandum of understanding between Saudia Group and Lilium signed in October 2022, marks the largest of its kind in the MENA region. The agreement includes a schedule of deposit and pre-delivery payments, timeline of future deliveries, guarantees on aircraft performance, and provisions on spare parts, maintenance, and repairs. In addition, the parties intend to sign a comprehensive "Lilium POWER-ON" agreement for aircraft fleet maintenance and support services.